ARCHIVES

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

This article is from The Cancer Letter archive.

Vol. 32 No. 36 | October 13, 2006

Download PDF Visit The Full Archive

Related Articles

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

In Brief: Arkansas, Iowa Appoint Center Directors; Broder Moves To Gene Sequencing Venture

August 14, 1998

New CEO Brings Managed Care Expertise To Network Of Academic Cancer Centers

January 24, 1997

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992

TGen and George Mason Form Precision Medicine Alliance

May 16, 2014